These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 9365619

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
    Remport A, Sasvári I, Toronyi E, Borka P, Lázár N, Járay J, Perner F.
    Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
    Kim HC, Park SB, Kim HT, Cho WH, Park CH.
    Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil/Neoral/steroid vs Neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients.
    Carmellini M, Vistoli F, Bellini R, Boggi U, Rindi P, Rizzo G, Mosca F.
    Transplant Proc; 1999 Nov; 31(1-2):1162-4. PubMed ID: 10083519
    [No Abstract] [Full Text] [Related]

  • 6. Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients.
    Park K, Kim SI, Moon JI, Kim YS, Kim MS.
    Transplant Proc; 1998 Nov; 30(7):3575. PubMed ID: 9838565
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM, Andrés A, Morales E, Herrero JC, Cubas A, Praga M, Hernández E, Ortuño T, Dominguez-Gil B, Carreño A, Delgado M, Manzanares C.
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract] [Full Text] [Related]

  • 9. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection.
    Behrend M, Lueck R, Pichlmayr R.
    Transplant Proc; 1997 Nov; 29(7):2927-9. PubMed ID: 9365617
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF, Górriz JL, Sancho A, Avila A, Alcoy E, Pallardó LM.
    Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract] [Full Text] [Related]

  • 17. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J.
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 19. Triple therapy with mycophenolate mofetil versus azathioprine.
    Muñiz ML, Amenabar J, Gómez-Ullate P, Urbizu J, Lampreabe I.
    Transplant Proc; 1999 Apr 27; 31(1-2):1144-6. PubMed ID: 10083512
    [No Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM, Lloveras J, Fernández-Crespo P, Mir M, Iñigo V, Manresa JM, Masramón J.
    Transplant Proc; 1999 Sep 27; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.